ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

American Health Fdn. Honors NCI On Act’s 20th Anniversary

December 13, 1991

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982